Pre-treatment differences and early response monitoring of neoadjuvant chemotherapy in breast cancer patients using magnetic resonance imaging: A systematic review

European Radiology

Volumn 22, Issue 12, 2012, Pages 2607-2616

  Prevos, R ^a   Smidt, M L ^a   Tjan Heijnen, V C G ^a,b   Van Goethem, M ^c   Beets Tan, R G ^a,b   Wildberger, J E ^a   Lobbes, M B I ^a,b  

^a MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

^c ANTWERP UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Breast cancer; MRI; Neoadjuvant chemotherapy; Response monitoring; Systematic review

Indexed keywords

CARBOPLATIN; CHOLINE; CONTRAST MEDIUM; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; EPIRUBICIN; FLUOROURACIL; GADOLINIUM PENTETATE; PACLITAXEL; PIRARUBICIN; TRASTUZUMAB;

AREA UNDER THE CURVE; ARTICLE; BLOOD FLOW; BLOOD VOLUME; BOLD SIGNAL; BREAST CANCER; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER MORPHOLOGY; CANCER PATIENT; COLLOID CARCINOMA; CONTRAST ENHANCEMENT; DIAGNOSTIC ACCURACY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; EARLY CONTRAST UPTAKE; EXTRACELLULAR EXTRAVASCULAR SPACE; HUMAN; INTRADUCTAL CARCINOMA; MAXIMAL ENHANCEMENT RATIO; MEAN TRANSIT TIME; MULTIPLE CYCLE TREATMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATIENT MONITORING; PEAK ENHANCEMENT; PRIORITY JOURNAL; RADIOLOGICAL PARAMETERS; RELATIVE BLOOD FLOW; RELATIVE BLOOD VOLUME; RELATIVE SIGNAL ENHANCEMENT; SENSITIVITY AND SPECIFICITY; SIGNAL INTENSITY RATIO; SIGNAL INTENSITY TIME CURVE; SMALL CELL CARCINOMA; SYSTEMATIC REVIEW; TRANSFER COEFFICIENT; TRANSFER RATE; TREATMENT RESPONSE; TTIME TO MAXIMAL ENHANCEMENT; TUMOR VOLUME;

ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BREAST NEOPLASMS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; NEOADJUVANT THERAPY;

EID: 84870370610     PISSN: 09387994     EISSN: 14321084     Source Type: Journal    
DOI: 10.1007/s00330-012-2653-5     Document Type: Article

References (33)

1. Mauri D, Pavlidis N, Ioannidis JP (2005) Neoadjuvant versus adjuvant systemic treatment in breast cancer: a meta-analysis. J Natl Cancer Inst 97: 188-194
2. Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN (2007) Overview of resistance to systemic therapy in patients with breast cancer. Adv Exp Med Biol 608: 1-22
3. Chagpar AB, Middleton LP, Sahin AA et al (2006) Accuracy of physical examination, ultrasonography, and mammography in predicting residual pathologic tumour size in patients treated with neoadjuvant chemotherapy. Ann Surg 243: 257-264
4. Hylton NM, Blume JD, Bernreuter WK et al (2012) Locally advanced breast cancer: MR imaging for prediction of response to neoadjuvant chemotherapy - results from ACRIN 6657/I-SPY TRIAL. Radiology 263: 663-672
5. Yuan Y, Chen XS, Liu SY, Shen KW (2010) Accuracy of MRI in prediction of pathologic complete response in breast cancer after preoperative therapy: a meta-analysis. Am J Roentgenol 195: 260-268
6. Cheung Y, Chen S, Su M et al (2003) Monitoring the size and response of locally advanced breast cancers to neoadjuvant chemotherapy (weekly paclitaxel and epirubicin) with serial enhanced MRI. Breast Canc Res Treat 78: 51-58
7. Pickles MD, Lowry M, Manton DJ, Gibbs P, Turnbull LW (2005) Role of dynamic contrast enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Breast Canc Res Treat 91: 1-10
8. Nagashima T, Sakakibara M, Nakamura R et al (2006) Dynamic enhanced MRI predicts chemosensitivity in breast cancer patients. Eur J Radiol 60: 270-274
9. Yu HJ, Chen J, Mehta RS, Nalcioglu O, Su M (2007) MRI measurements of tumour size and pharmacokinetic parameters as early predictors of response in breast cancer patients undergoing neoadjuvant anthracycline chemotherapy. JMRI 26: 615-623
10. Ah-See M, Makris A, Taylor NJ et al (2008) Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer. Clin Cancer Res 14: 6580-6589
11. Loo CE, Teertstra HJ, Rodenhuis S et al (2008) Dynamic contrastenhanced MRI for prediction of breast cancer response to neoadjuvant chemotherapy: initial results. AJR Am J Roentgenol 191: 1331-1338
12. Baek H, Chen J, Nie K et al (2009) Predicting pathologic response to neoadjuvant chemotherapy in breast cancer using 1H MR spectroscopy. Radiology 251: 653-662
13. Park SH, Moon WK, Cho N et al (2010) Diffusion-weighted MR imaging: pretreatment prediction of response to neoadjuvant chemotherapy in patients with breast cancer. Radiology 257: 56-63
14. Li SP, Taylor NJ, Makris A et al (2010) Primary human breast adenocarcinoma: imaging and histologic correlates of intrinsic susceptibility-weighted MR imaging before and during chemotherapy. Radiology 257: 643-652
15. Uematsu T, Kasami M, Yuen S (2010) Neoadjuvant chemotherapy for breast cancer: correlation between the baseline MR imaging findings and responses to therapy. Eur Radiol 20: 2315-2322
16. Wang X, Peng W, Tan H, Xin C, Mao J (2010) Evaluation of dynamic contrast-enhanced MRI in monitoring early response of locally advanced breast cancer to neoadjuvant chemotherapy. Chin-Ger J Clin Oncol 9: 637-642
17. Yu Y, Jiang Q, Miao Yet al (2010) Quantitative analysis of clinical dynamic contrast-enhanced MR imaging for evaluating treatment response in human breast cancer. Radiology 257: 47-55
18. Fan B, Wang X, Yang X, Zhong H, Wu C, Jiang X (2011) Blood oxygen level-dependent MRI for the monitoring of neoadjuvant chemotherapy in breast carcinoma: initial experience. Magn Reson Imag 29: 153-159
19. Fangberget A, Nilsen LB, Hole KH et al (2011) Neoadjuvant chemotherapy in breast cancer-response evaluation and prediction of response to treatment using dynamic contrast-enhanced and diffusion-weighted MR imaging. Eur Radiol 21: 1188-1199
20. Li X, Cheng L, Liu M et al (2012) DW-MRI ADC values can predict treatment response in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy. Med Oncol 29: 425-431
21. McLaughlin R, Hylton N (2011) MRI in breast cancer therapy monitoring. NMR Biomed 24: 712-720
22. Tofts PS, Kermode AG (1991) Measurement of the blood-brain barrier permeability and leakage space using dynamic MR imaging. 1. Fundamental concepts. Magn Reson Med 17: 357-367
23. O'Connor JPB, Jackson A, Parker GJM, Jayson GC (2007) DCEMRI biomarkers in the clinical evaluation of antiangiogenic and vascular disrupting agents. Br J Cancer 96: 189-195
24. Zwick S, Brix G, Tofts PS et al (2010) Simulation-based comparison of two approached frequently used for dynamic contrastenhanced MRI. Eur Radiol 20: 432-442
25. Woodhams R, Ramadan S, Stanwell P et al (2011) Diffusionweighted imaging of the breast: principles and clinical applications. Radiographics 31: 1059-1084
26. Esteva FJ, Hortobagyi GN (2008) Can early response assessment guide neoadjuvant chemotherapy in early-stage breast cancer? J Natl Canc Inst 100: 521-523
27. Bear HD, Anderson S, Brown A et al (2003) The effect of tumour response of adding sequential preoperative docetaxel to preoperative doxorubicin and cyclophosphamide: preliminary results from National Surgical Adjuvant Breast and Bowel Project Protocol B-27. J Clin Oncol 21: 4165-4174
28. Smith IC, Heys SD, Hutckeon AW et al (2002) Neoadjuvant chemotherapy in breast cancer: significantly enhanced response with docetaxel. J Clin Oncol 20: 1456-1466
29. Von Minckwitz G, Kummel S, Vogel P et al (2008) Intensified neoadjuvant chemotherapy in early-responding breast cancer: phase III randomized GeparTrio study. J Natl Cancer Inst 100: 552-562
30. Von Minckwitz G, Kummel S, Vogel P et al (2008) Neoadjuvant vinorelbine-capecitabine versus docetaxel-doxorubicincyclophosphamide in early nonresponsive breast cancer: phase III randomized GeparTrio trial. J Natl Canc Inst 100: 542-551
31. Wu L, Hu J, Gu H, Hua J, Chen J, Xu J (2012) Can diffusionweighted MR imaging and contrast-enhanced MR imaging precisely evaluate and predict pathological response to neoadjuvant chemotherapy on patients with breast cancer? Breast Cancer Res Treat 135: 17-28
32. Sardanelli F, Boetes C, Borisch B et al (2010) Magnetic resonance imaging of the breast: recommendations from the EUSOMA work group. Eur J Cancer 46: 1296-1316
33. Mann RM, Kuhl CK, Kinkel K, Boetes C (2008) Breast MRI: guidelines from the European Society of Breast Imaging. Eur Radiol 18: 1307-1318